ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™
reshapecare™ is a HIPAA-compliant, effective, convenient virtual health coaching program delivered through ReShape Lifesciences’™ innovative app, which enhances behavior change through patient engagement. reshapecare™ is doctor prescribed and may be covered by insurance for up 26 visits per reimbursement year. In partnership with physicians, the service utilizes video-based counseling with board certified health coaches in order to help patients both set and achieve their health and wellness goals including implementing behavioral changes to improve patients’ sleep, nutrition, exercise and stress levels. reshapecare™ is appropriate for all weight loss patients including medical weight loss patients, and pre- and post-surgical bariatric patients.
OpenLoop’s telehealth technology provides access to 7,000 in-network licensed clinicians, available 24x7 in all 50 states, including specialists in weight-loss and metabolic health solutions. Additionally, OpenLoop’s in-network clinicians now serve patients covered by over 600 payers including Medicare, Medicaid and every major private insurer.
“As the obesity epidemic continues to grow, affecting the expansion of the virtual weight loss market, we are emboldened by this agreement with OpenLoop, in that it will allow us to vastly extend the reach of reshapecare™, our proprietary, digital therapeutic weight loss and wellness program,” stated
“OpenLoop is excited to partner with ReShape Lifesciences™, an innovative company dedicated to tackling the challenges faced by patients with obesity in the U.S.,” stated
About ReShape Lifesciences™
ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the
OpenLoop was co-founded by CEO, Dr.
Forward-Looking Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as "expect," "plan," "anticipate," "could," "may," "intend," "will," "continue," "future," other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements that the agreement with OpenLoop will allow us to vastly extend the reach of reshapecare™ and that we expect to fully launch reshapecare™, with easier patient access empowered by OpenLoop, over the coming months. These and additional risks and uncertainties are described more fully in the company's filings with the
ReShape Lifesciences Investor Contact:
Chief Financial Officer
Investor Relations Contact:
Source: ReShape Lifesciences Inc